Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.43 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.43 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.43 |
| ▸ | CAPN1 | P07384 | 4/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.41 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | GRB2 | P62993 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13448495 | 0.92 | ITGB3 (0.49) | APLNROPRM1OPRK1ITGB3ITGA2B | |
| SCHEMBL13795060 | 0.92 | ITGB3 (0.49) | APLNROPRM1OPRK1ITGB3ITGA2B | |
| SCHEMBL28665808 | 0.92 | ITGB3 (0.49) | APLNROPRM1OPRK1ITGB3ITGA2B | |
| SCHEMBL29637996 | 0.90 | APLNR (0.46) | APLNROPRM1OPRK1ITGB3ITGA2B | |
| SCHEMBL13083553 | 0.86 | APLNR (0.43) | APLNROPRM1OPRK1CAPN1NMUR2 | |
| SCHEMBL30342385 | 0.84 | CAPN1 (0.45) | APLNRITGB3ITGA2BCAPN1F2 | |
| SCHEMBL15976537 | 0.82 | APLNR (0.41) | APLNROPRM1OPRK1CAPN1GRB2 | |
| SCHEMBL10702151 | 0.79 | DPP4 (0.52) | OPRM1ITGB3ITGA2BF2 | |
| SCHEMBL10702146 | 0.79 | DPP4 (0.52) | OPRM1ITGB3ITGA2BF2 | |
| SCHEMBL30361589 | 0.78 | NTSR2 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022120791-A1 | NOVEL USE OF SELEPRAVASTATIN | 兆科药业(广州)有限公司 | 2022-06-16 | — | — | WO | disclosed |